BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6367693)

  • 1. Cytomorphometric characterization of NHL(non-Hodgkin's lymphomas) of low and high grade malignancy.
    Haroske G; Ehlers U; Ehlers HM; Kunze KD
    Arch Geschwulstforsch; 1984; 54(1):41-51. PubMed ID: 6367693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometry in evaluating large cell malignant lymphomas in lymph node biopsies.
    Mihailovici MS; Roznovanu S; Cămărniceanu C
    Morphol Embryol (Bucur); 1989; 35(3):195-8. PubMed ID: 2530444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar ultrastructure in low- and high-grade non-Hodgkin's lymphomas.
    Goodlad JR; Crocker J; Mccartney JC
    J Pathol; 1991 Mar; 163(3):233-7. PubMed ID: 2013826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
    Mathur S; Dawar R; Verma K
    Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
    Jakić-Razumović J; Labar B; Cör A; Radman I
    Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric characterization of diffuse large-cell (histiocytic) lymphomas.
    van der Valk P; Hermans J; Brand R; Cornelisse CJ; Spaander PJ; Meijer CJ
    Am J Pathol; 1982 Jun; 107(3):327-35. PubMed ID: 7044134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases].
    Radaszkiewicz T
    Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transformation of malignant non-Hodgkin's lymphomas from low- to high-grade malignancy].
    Herait P; Audouin J; Rio B; Zylberait D; Marie JP; Diebold J; Zittoun R
    Ann Med Interne (Paris); 1986; 137(4):342-5. PubMed ID: 3777743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleolar organizer regions and mitotic activity in non-Hodgkin's lymphoma].
    Dubrovskiĭ ACh; Kliukina LB
    Arkh Patol; 1997; 59(1):25-30. PubMed ID: 9139602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An application of mathematical morphology to analysis of the size and shape of nuclei in tissue sections of non-Hodgkin's lymphoma.
    Lesty C; Raphael M; Nonnenmacher L; Leblond-Missenard V; Delcourt A; Homond A; Binet JL
    Cytometry; 1986 Mar; 7(2):117-31. PubMed ID: 3948605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas.
    van der Valk P; Mosch A; Kurver PJ; Meijer CJ
    J Clin Pathol; 1983 Mar; 36(3):289-97. PubMed ID: 6600749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
    Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
    Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-Hodgkin's lymphomas: principles and application of the Kiel classification].
    Lennert K
    Verh Dtsch Ges Pathol; 1992; 76():1-13. PubMed ID: 1283238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant lymphoma with medium-sized macronucleolated cells in the dog: involvement of an original cell from the marginal zone of the reactive lymph node].
    Magnol JP; Fournel C; Marchal T; Chabanne L; Bryon PA; Felman P
    Bull Acad Natl Med; 1995 Jan; 179(1):51-65. PubMed ID: 7788447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphomas with primary bone manifestation.
    Vassallo J; Roessner A; Vollmer E; Grundmann E
    Pathol Res Pract; 1987 Jun; 182(3):381-9. PubMed ID: 3628096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.